用于药物聚合物混合性评估的可溶性参数的多变量分析,用于制备拉洛西芬化无形固体分散物的药物聚合物混合性评估
Guilherme G Moreira1, Stephânia F Taveira1, Felipe T Martins2
1Laboratory of Nanosystems and Drug Delivery Devices (NanoSYS), School of Pharmacy, Universidade Federal de Goiás, Goiânia, Goiás, 74.605-170, Brazil.
AAPS PharmSciTech
|June 6, 2024
概括
这项研究使用溶解度参数来预测和选择固体分散的聚合物,提高药物溶解度. 该方法成功地分类了聚合物-药物混合性,有助于为固体溶液选择最佳辅助剂.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 物理化学 物理化学
背景情况:
- 药物溶解性对于有效的药物输送至关重要.
- 固体分散增强了药物的溶解性,但取决于药物-聚合物混合性.
- 需要用于选择适当的聚合物载体的预测方法.
研究的目的:
- 使用可溶性参数对RX-HCl固体分散物的聚合物载体进行分类和选择.
- 评估RX-HCl与各种聚合物的混合性.
- 通过实验性表征来验证预测模型.
主要方法:
- 使用组贡献方法计算RX-HCl的汉森可溶性参数 (HSP).
- 多变量分析包括等级聚类和主要组件回归.
- 实验性生产通过溶剂造的固体分散物.
- 使用X射线衍射,红外光谱和扫描电子显微镜进行表征.
主要成果:
- RX-HCl 的汉森溶解度参数 (HSP) 为 23.52 MPa.
- 聚合物药物组合被分为可混合 (11),部分可混合 (15) 和不可混合 (10) 的分类.
- 在降低晶度和计算的HSP/RED值之间发现了显著的相关性.
- 光谱分析表明,键有助于无形化.
结论:
- 组贡献方法和HSP分析有效预测固体分散的聚合物-药物混合性.
- 这种系统的方法有助于选择最佳的辅助剂,以创建固体溶液.
- 这些发现有助于开发增强药物可溶性配方.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
299
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
299
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.3K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.3K
Factors Influencing Drug Absorption: Drug Dissolution
466
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
466
Factors Influencing Drug Absorption: Pharmaceutical Parameters
129
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
129
Factors Affecting Dissolution: Particle Size and Effective Surface Area
802
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
802
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
198
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
198


